App for Living –
December 11, 2018 – “Digital technologies and data science have incredible potential to unlock the next chapter of medical innovation and to help individuals finally take control of their own health in a meaningful way,” Richard Francis, CEO of Sandoz Inc. said. “New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their therapies and thus improve patient outcomes. At Sandoz, we are proud to be a joint pioneer in this exciting new field.” ReSET-O is a 12-week prescription digital therapeutic for opioid abuse that works similarly to the Community Reinforcement Approach. Users participate in a series of interactive therapy sessions that use CBT and skill-building exercises via text, audio, video, animations, and graphics.
